-15.9% to -22.1%. 5 The American Society of Echocardiography suggests a value above -20% with a standard deviation of ±2% as likely to be normal. 6 To date, most strain data have come from nonrandomized, retrospective studies. GLS has been proposed for the detection of myocardial ischemia, 7 to differentiate among various hypertrophy etiologies, 8 to monitor therapy, and as a tool to detect heart disease in the preclinical stage. 9 A recent 2017 review identifies four settings in which GLS can provide additional (if not potentially incremental) clinical utility: undifferentiated left ventricular hypertrophy; assessment of cardiotoxicity; aortic stenosis; and ischemic heart disease. 4 The use of 2D-ST has been expanded and validated for the other cardiac chambers (right ventricle and left and right atrium) 1 as well as the aortic wall.
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Ultrasound systems are now capable of acquiring realtime volumetric LV data. Three-dimensional (3D) techniques can measure all strain components in all LV segments and LV torsion from a single acquisition.
11 3D speckle tracking echocardiography (3D-STE) thus offers an opportunity to overcome a significant limitation of 2D-STE: out-of-plane speckle motion.
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technique for the assessment of LV global systolic function, highly correlated with left ventricular ejection fraction and Doppler-derived cardiac output.
14 Subsequent studies in different clinical scenarios such as ischemia and hypertensive and valvular heart disease have provided further evidence of the utility of LV 3D-STE. 11 In this issue of the Journal, Guedes et al., 15 using both classic and advanced echocardiographic parameters, present a study of a group of patients with myotonic dystrophy type 1 (DM1) with no established cardiovascular disease plus a control group of healthy subjects. Regarding advanced imaging, the authors focused on 3D LV myocardial mechanics assessed with an Artida scanner (Toshiba ® Medical Systems). The following parameters of LV cardiac mechanics were calculated: LV longitudinal, radial and circumferential strain; LV area tracking; and twist. The authors concluded that DM1 patients had lower values of 3D LV longitudinal strain than the control group. Moreover, assessment of 2D myocardial mechanics did not identify differences between the groups, in contrast to 3D assessment. Based on previous data from clinical studies, 16 2D-STE 17 and cardiac MRI of myocardial fibrosis 18 in DM1 patients, the authors theorized that this 3D LV longitudinal strain reduction could represent subclinical myocardial damage.
Although these results are of interest, some limitations are to be noted. Speckle-tracking analyses can be complex and time-consuming, and can generally only be obtained from high-quality images. It is therefore important to provide data regarding feasibility. Secondly, inter-and intraobserver variability in assessment of cardiac mechanics (and echocardiography in general) is a concern. The intra-class correlation coefficient can be used, but, for simplicity, other measures of variability may be more appropriate, such as the absolute difference divided by the mean of repeated observations, expressed as a percentage. Finally, the overlap of values between cases and controls makes it unlikely that 3D-STE will in fact add real value in clinical practice.
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